Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1970 1
1972 2
1974 1
1975 2
1976 1
1977 1
1978 2
1979 1
1980 2
1981 1
1982 2
1983 5
1984 5
1985 12
1986 6
1987 10
1988 5
1989 10
1990 8
1991 9
1992 4
1993 9
1994 2
1995 2
1996 1
1998 1
1999 2
2000 2
2001 3
2002 3
2004 1
2009 3
2010 1
2011 4
2012 1
2013 3
2014 1
2015 3
2016 6
2017 4
2020 2
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Results by year
Filters applied: . Clear all
Page 1
Development of whole sporozoite malaria vaccines.
Hollingdale MR, Sedegah M. Hollingdale MR, et al. Expert Rev Vaccines. 2017 Jan;16(1):45-54. doi: 10.1080/14760584.2016.1203784. Epub 2016 Jul 18. Expert Rev Vaccines. 2017. PMID: 27327875 Review.
Malaria and the liver.
Hollingdale MR. Hollingdale MR. Hepatology. 1985 Mar-Apr;5(2):327-35. doi: 10.1002/hep.1840050230. Hepatology. 1985. PMID: 3920137 Review. No abstract available.
Anti-sporozoite antibodies.
Hollingdale MR. Hollingdale MR. Bull World Health Organ. 1990;68 Suppl(Suppl):47-51. Bull World Health Organ. 1990. PMID: 2094591 Free PMC article. Review.
Non-CS pre-erythrocytic protective antigens.
Hollingdale MR, Aikawa M, Atkinson CT, Ballou WR, Chen GX, Li J, Meis JF, Sina B, Wright C, Zhu JD. Hollingdale MR, et al. Immunol Lett. 1990 Aug;25(1-3):71-6. doi: 10.1016/0165-2478(90)90094-7. Immunol Lett. 1990. PMID: 2283163
IMRAS-Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS.
Sedegah M, Hollingdale MR, Ganeshan H, Belmonte M, Huang J, Belmonte A, Inoue S, Velasco R, Hickey B, Teneza-Mora N, Lumsden J, Reyes S, Banania JG, Reyes A, Guzman I, Richie TL, Epstein JE, Villasante E. Sedegah M, et al. Among authors: hollingdale mr. PLoS One. 2021 Aug 20;16(8):e0256396. doi: 10.1371/journal.pone.0256396. eCollection 2021. PLoS One. 2021. PMID: 34415964 Free PMC article.
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
Sklar MJ, Maiolatesi S, Patterson N, Sedegah M, Limbach K, Teneza-Mora N, Chuang I, Hollis-Perry KM, Banania JG, Guzman I, Ganeshan H, Reyes S, Hollingdale MR, Wong M, Lindstrom A, Reyes A, Alcorta Y, Garver L, Bankard K, Belmonte A, Belmonte M, Huang J, Gowda K, Inoue S, Velasco R, Bergmann-Leitner E, Hutter J, Lee T, Adams N, Chaudhury S, Hunt D, Tamminga C, Berrie E, Bellamy D, Bittaye M, Ewer K, Diggs C, Soisson LA, Lawrie A, Hill A, Richie TL, Villasante E, Epstein JE, Duplessis CA. Sklar MJ, et al. Among authors: hollingdale mr. PLoS One. 2021 Sep 8;16(9):e0256980. doi: 10.1371/journal.pone.0256980. eCollection 2021. PLoS One. 2021. PMID: 34495988 Free PMC article. Clinical Trial.
Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge.
Smith EC, Limbach KJ, Rangel N, Oda K, Bolton JS, Du M, Gowda K, Wang J, Moch JK, Sonawane S, Velasco R, Belmonte A, Danner R, Lumsden JM, Patterson NB, Sedegah M, Hollingdale MR, Richie TL, Sacci JB Jr, Villasante ED, Aguiar JC. Smith EC, et al. Among authors: hollingdale mr. PLoS One. 2020 May 14;15(5):e0232234. doi: 10.1371/journal.pone.0232234. eCollection 2020. PLoS One. 2020. PMID: 32407410 Free PMC article.
146 results